Pulse: Oh Oh Oh So Many Uses! GLP-1 Receptor Agonists in Special Populations: Dumping Syndrome, Depression, and Retinopathy

April 3, 2024

New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.

GLP-1 Receptor Agonists (GLP1RAs) are commonly used medications in patients with Type II Diabetes Mellitus and/or obesity. As their use expands into more patient populations, questions arise regarding their safety and efficacy in special populations. This presentation will increase pharmacist understanding of the risks and benefits of GLP1RA use in patients with dumping syndrome, depression, and diabetic retinopathy.

Target Audience

Pharmacist

Learning Objectives

1. Describe the mechanism of action of glucagon-like peptide-1 receptor agonists (GLP1RAs) as it relates to dumping syndrome, depression, and diabetic retinopathy.
2. Recognize the risks versus benefits of GLP1RA use in dumping syndrome, depression, and diabetic retinopathy.
3. Discuss GLP1RAs' place in therapy for the treatment of dumping syndrome, depression, and diabetic retinopathy.

Additional Information

AttachmentSize
PDF icon Disclosure Slides_Korte.pdf284.59 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
Course opens: 
04/03/2024
Course expires: 
05/03/2024
Event starts: 
04/03/2024 - 12:00pm EDT
Event ends: 
04/03/2024 - 1:00pm EDT

New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.

GLP-1 Receptor Agonists (GLP1RAs) are commonly used medications in patients with Type II Diabetes Mellitus and/or obesity. As their use expands into more patient populations, questions arise regarding their safety and efficacy in special populations. This presentation will increase pharmacist understanding of the risks and benefits of GLP1RA use in patients with dumping syndrome, depression, and diabetic retinopathy.

UPMC Presbyterian
Pittsburgh, PA
United States

Leah Korte, PharmD

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Pharmacy (CPE)

This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.

 

Available Credit

  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
Please login or register to take this course.